Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library

被引:18
作者
Lynch, Caitlin [1 ]
Sakamuru, Srilatha [1 ]
Huang, Ruili [1 ]
Niebler, Jake [1 ]
Ferguson, Stephen S. [2 ]
Xia, Menghang [1 ]
机构
[1] NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA
[2] NIEHS, Div Natl Toxicol Program, NIH, Durham, NC USA
基金
美国国家卫生研究院;
关键词
Agonist; Pregnane X receptor; Quantitative high-throughput screening; Tox21; CYP3A4; GENE-EXPRESSION; DRUG-METABOLISM; PXR; RESISTANCE; PROLIFERATION; ANTAGONIST; CAR;
D O I
10.1016/j.bcp.2020.114368
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pregnane X receptor (PXR; NR1I2) is an important nuclear receptor whose main function is to regulate enzymes within drug metabolism. The main drug metabolizing enzyme regulated by PXR, cytochrome P450 (CYP) 3A4, accounts for the metabolism of nearly 50% of all marketed drugs. Recently, PXR has also been identified as playing a role in energy homeostasis, immune response, and cancer. Due to its interaction with these important roles, alongside its drug-drug interaction function, it is imperative to identify compounds which can modulate PXR. In this study, we screened the Tox21 10,000 compound collection to identify hPXR agonists using a stable hPXR-Luc HepG2 cell line. A pharmacological study in the presence of a PXR antagonist was performed to confirm the activity of the chosen potential hPXR agonists in the same cells. Finally, metabolically competent cell lines - HepaRG and HepaRG-PXR-Knockout (KO) - were used to further confirm the potential PXR activators. We identified a group of structural clusters and singleton compounds which included potentially novel hPXR agonists. Of the 21 selected compounds, 11 potential PXR activators significantly induced CYP3A4 mRNA expression in HepaRG cells. All of these compounds lost their induction when treating HepaRG-PXR-KO cells, confirming their PXR activation. Etomidoline presented as a potentially selective agonist of PXR. In conclusion, the current study has identified 11 compounds as potentially novel or not well-characterized PXR activators. These compounds should further be studied for their potential effects on drug metabolism and drug-drug interactions due to the immense implications of being a PXR agonist.
引用
收藏
页数:14
相关论文
共 49 条
[1]   Characterization of human cytochrome P450 induction by pesticides [J].
Abass, Khaled ;
Lamsa, Virpi ;
Reponen, Petri ;
Kublbeck, Jenni ;
Honkakoski, Paavo ;
Mattila, Sampo ;
Pelkonen, Olavi ;
Hakkola, Jukka .
TOXICOLOGY, 2012, 294 (01) :17-26
[2]   The Tox21 robotic platform for the assessment of environmental chemicals - from vision to reality [J].
Attene-Ramos, Matias S. ;
Miller, Nicole ;
Huang, Ruili ;
Michael, Sam ;
Itkin, Misha ;
Kavlock, Robert J. ;
Austin, Christopher P. ;
Shinn, Paul ;
Simeonov, Anton ;
Tice, Raymond R. ;
Xia, Menghang .
DRUG DISCOVERY TODAY, 2013, 18 (15-16) :716-723
[3]  
Austin C., 2016, PRACTICAL GUIDE SUPP
[4]  
Blumberg B, 2009, NUCL RECEPT SIGNAL, V7
[5]   Human pregnane x receptor and resistance to chemotherapy in prostate cancer [J].
Chen, Yakun ;
Tang, Yong ;
Wang, Man-Tzu ;
Zeng, Su ;
Nie, Daotai .
CANCER RESEARCH, 2007, 67 (21) :10361-10367
[6]   Pregnane X receptor as a target for treatment of inflammatory bowel disorders [J].
Cheng, Jie ;
Shah, Yatrik M. ;
Gonzalez, Frank J. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (06) :323-330
[7]   Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic [J].
Dantzig, AH ;
Law, KL ;
Cao, J ;
Starling, JJ .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (01) :39-50
[8]   Flavonoids activate activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells [J].
Dong, Hanqing ;
Lin, Wenwei ;
Wu, Jing ;
Chen, Taosheng .
BMC BIOCHEMISTRY, 2010, 11
[9]   Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins [J].
Gerets, H. H. J. ;
Tilmant, K. ;
Gerin, B. ;
Chanteux, H. ;
Depelchin, B. O. ;
Dhalluin, S. ;
Atienzar, F. A. .
CELL BIOLOGY AND TOXICOLOGY, 2012, 28 (02) :69-87
[10]  
Huang RL, 2016, METHODS MOL BIOL, V1473, P111, DOI 10.1007/978-1-4939-6346-1_12